We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
-3.08%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$307M
AUM Growth
+$41.6M
Cap. Flow
+$61.2M
Cap. Flow %
19.9%
Top 10 Hldgs %
95.94%
Holding
27
New
5
Increased
4
Reduced
2
Closed
3

Top Buys

Rank Stock Value
1
CDNA icon
CareDx
CDNA
+$30.5M
2
A icon
Agilent Technologies
A
+$27.2M
3
DNA icon
Ginkgo Bioworks
DNA
+$21.1M
4
RVTY icon
Revvity
RVTY
+$19.9M
5
TWST icon
Twist Bioscience
TWST
+$14.3M

Top Sells

Rank Stock Value
1
AMRS
Amyris Inc.
AMRS
+$36.3M
2
NEO icon
NeoGenomics
NEO
+$22.2M
3
ILMN icon
Illumina
ILMN
+$15.7M
4
GH icon
Guardant Health
GH
+$12.3M
5
HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
+$841K

Sector Composition

Rank Sector Weight
1 Healthcare 97.85%
2 Technology 0.88%
3 Financials 0.43%
4 Communication Services 0.27%
5 Consumer Discretionary 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTRA icon
1
Natera
NTRA
$46.9B
$61.7M 20.06%
553,381
+95,400
+21% +$10.9M
CDNA icon
2
CareDx
CDNA
$2.41B
$58.3M 18.98%
920,491
+399,975
+77% +$30.5M
TMO icon
3
Thermo Fisher Scientific
TMO
$227B
$44.7M 14.55%
78,300
+15,300
+24% +$8.4M
TECH icon
4
Bio-Techne
TECH
$11.3B
$26.5M 8.63%
218,844
+96,640
+79% +$11.8M
A icon
5
Agilent Technologies
A
$43.9B
$26.5M 8.62%
+168,150
New +$27.2M
RVTY icon
6
Revvity
RVTY
$13.3B
$19.6M 6.36%
+112,850
New +$19.9M
DNA icon
7
Ginkgo Bioworks
DNA
$519M
$17.6M 5.74%
+43,245
New +$21.1M
GH icon
8
Guardant Health
GH
$21.9B
$15.9M 5.16%
126,824
-103,771
-45% -$12.3M
TWST icon
9
Twist Bioscience
TWST
$8.93B
$13.4M 4.36%
+125,175
New +$14.3M
NEO icon
10
NeoGenomics
NEO
$2.14B
$10.7M 3.49%
222,222
-480,000
-68% -$22.2M
SLGC
11
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$4.97M 1.62%
+400,988
New +$4.52M
GOOGL icon
12
Alphabet (Google) Class A
GOOGL
$4.22T
$815K 0.27%
6,100
– –
MSFT icon
13
Microsoft
MSFT
$3.6T
$769K 0.25%
2,726
– –
NVDA icon
14
NVIDIA
NVDA
$5.27T
$752K 0.24%
36,280
– –
AMZN icon
15
Amazon
AMZN
$2.87T
$657K 0.21%
4,000
– –
ADBE icon
16
Adobe
ADBE
$108B
$630K 0.21%
1,094
– –
PHYS icon
17
Sprott Physical Gold
PHYS
$16.2B
$630K 0.21%
45,626
– –
JPM icon
18
JPMorgan Chase
JPM
$950B
$616K 0.2%
13,762
– –
AAPL icon
19
Apple
AAPL
$4.62T
$566K 0.18%
4,000
– –
SYK icon
20
Stryker
SYK
$130B
$475K 0.15%
1,800
– –
CVX icon
21
Chevron
CVX
$404B
$448K 0.15%
4,420
– –
ISRG icon
22
Intuitive Surgical
ISRG
$141B
$437K 0.14%
1,320
– –
V icon
23
Visa
V
$682B
$403K 0.13%
1,809
– –
GS icon
24
Goldman Sachs
GS
$297B
$315K 0.1%
833
– –
ILMN icon
25
Illumina
ILMN
$31B
– –
-34,063
Closed -$15.7M
1
2

Similar funds

SFC
Swisher Financial Concepts Westerville, Ohio $159M AUM 23.09% 1-Year Est. Return
ACP
Argyle Capital Partners Los Angeles, California $159M AUM 21.07% 1-Year Est. Return
CW
Cooksen Wealth The Woodlands, Texas $159M AUM 23.21% 1-Year Est. Return
SG
Stanich Group Montauk, New York $159M AUM 24.04% 1-Year Est. Return
LA
Lakeside Advisors Seattle, Washington $159M AUM 11.13% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $159M AUM 18.94% 1-Year Est. Return
JWM
JP Wealth Management Mt. Pleasant, South Carolina $159M AUM 19.83% 1-Year Est. Return
AC
Agman Capital Omaha, Nebraska $159M AUM

Blue Water Life Science Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Blue Water Life Science Advisors held 27 positions worth $307M, up 16% from $266M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Blue Water Life Science Advisors deployed $61.2M of net new capital in Q3 2021, opening 5 new positions and adding to 4 existing holdings. Its largest new stake was Agilent Technologies: 168,150 shares worth $26.5M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 84% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was NeoGenomics, an estimated $22.2M trimmed.

  • Blue Water Life Science Advisors's largest Q3 2021 buy was Agilent Technologies: 168,150 shares worth $26.5M.
  • Blue Water Life Science Advisors added most to CareDx in Q3 2021, an estimated $30.5M increase.
  • Blue Water Life Science Advisors's biggest Q3 2021 reduction was NeoGenomics, cutting an estimated $22.2M.
  • Blue Water Life Science Advisors fully exited Amyris Inc. in Q3 2021, selling an estimated $36.3M.
  • Blue Water Life Science Advisors's ten largest holdings make up 96% of its $307M portfolio in Q3 2021.
  • Blue Water Life Science Advisors opened 5 new positions and closed 3 in Q3 2021.
  • Blue Water Life Science Advisors's portfolio value rose 16% quarter-over-quarter to $307M.

Based on Blue Water Life Science Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.